CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00218010
NCT00218010N/ACompleted

Breastfeeding Among Methadone Maintained Women

National Institute on Drug Abuse (NIDA)·observational·Posted Sep 22, 2005·Updated Jan 12, 2017

In Brief

An observational study for Breast Feeding and Opioid-Related Disorders. Completed, enrolled 25 participants across 1 site.

Detailed Summary

Methadone is a drug that offers significant therapeutic benefits to opiate dependent women who are pregnant. Currently, it is the treatment of choice for this group of people. The purpose of this study is to determine the amount of methadone in the breast milk of women who are breastfeeding and taking methadone for opiate addiction. In addition, this study will evaluate the effects of methadone on infant neurobehavior.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartNov 1, 2000
Primary CompletionAug 1, 2005
Study CompletionSep 1, 2005
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 20.8 years ago